Tiffany represents life science, pharmaceutical, and technology companies in commercial, antitrust, and intellectual property disputes, handling all aspects of litigation from case inception through trial. Her litigation experience spans a broad range of subject matters that are critical to life science and pharmaceutical companies, from regulatory inspections to supply agreements to market access issues.

Tiffany also works with clients on transactional and FDA regulatory matters, including R&D collaboration agreements, patent licensing, and Orange Book listings. She has counseled clients and played an active role in inter partes review proceedings, intellectual property due diligences in connection with corporate transactions, and validity and freedom-to-operate opinion work.

Over the years, Tiffany has actively volunteered within the firm as well as in various professional associations. She is currently a member of the firm’s Diversity Committee (2023) and previously served on its Pro Bono Committee (2020-22). She is also currently part of the leadership of Boston Intellectual Property Law Association, serving as Chair of its Antitrust Committee.